Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase
Hepatitis C virus (HCV) infection or HCV-related liver diseases are now shown to cause more than 350,000 deaths every year. Adaptability of HCV genome to vary its composition and the existence of multiple strains makes it more difficult to combat the emergence of drug-resistant HCV infections. Among...
Saved in:
Main Authors: | , , , , |
---|---|
其他作者: | |
格式: | Article |
語言: | English |
出版: |
2015
|
主題: | |
在線閱讀: | https://hdl.handle.net/10356/97886 http://hdl.handle.net/10220/38515 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | Nanyang Technological University |
語言: | English |